 Bragar Eagel Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Sorrento Therapeutics, Inc. SRNE, Carnival Corporation Plc NYSE: CCL, CUK, Wells Fargo and Company WFC, and Hebron Technology HEBT. On May 15, 2020, Sorrento announced that it had discovered an antibody that had demonstrated 100 inhibition of SARS-CoV-2 virus infection. On that same day, Defendant Henry Ji, founder and Chief Executive Officer of Sorrento referred to Sorrentos breakthrough as a cure. 